STOCK DAY MEDIA
(NASDAQ:PSYC)
21/09/2023 14:15
PSYC Corp. Acquires Stock Day Media, Talks Scalability and Revenue Generation on The Stock Day Podcast
Lire la news
Voir tous les communiqués de Stock Day Media
STOCK DAY MEDIA
(NASDAQ:PSYC)
19/09/2023 15:00
CANAQUEST Announces Award of European Cannabinoid Patent
Lire la news
Voir tous les communiqués de Stock Day Media
STOCK DAY MEDIA
(NASDAQ:PSYC)
14/09/2023 15:25
Onfolio Holdings Inc. CEO Dom Wells is Featured on The Stock Day Podcast
Lire la news
Voir tous les communiqués de Stock Day Media
STOCK DAY MEDIA
(NASDAQ:PSYC)
12/09/2023 16:10
NaturalShrimp Discusses Company Update and Other Matters of Interest with The Stock Day Podcast
Lire la news
Voir tous les communiqués de Stock Day Media
STOCK DAY MEDIA
(NASDAQ:PSYC)
09/08/2023 15:35
MIRA Pharmaceuticals, Inc. Discusses Potential of Revolutionary THC Analog Drug, MIRA1a, with The Stock Day Podcast
Lire la news
Voir tous les communiqués de Stock Day Media
STOCK DAY MEDIA
(NASDAQ:PSYC)
07/08/2023 19:45
LightPath Technologies, Inc. Discusses Significance of Its Proprietary Germanium-Alternative, BlackDiamond(TM), with The Stock Day Podcast
Lire la news
Voir tous les communiqués de Stock Day Media
STOCK DAY MEDIA
(NASDAQ:PSYC)
26/07/2023 15:30
CanaQuest Awarded Best Global Medical Cannabinoid Development Company 2023 by UK-based Global Health & Pharma for their 8th Annual Healthcare and Pharmaceutical Program
Lire la news
Voir tous les communiqués de Stock Day Media
STOCK DAY MEDIA
(NASDAQ:PSYC)
25/04/2023 15:30
CanaQuest and Neeka Health Sign Agreement to Conduct Clinical Studies with Mentanine(R)
Lire la news
Voir tous les communiqués de Stock Day Media
STOCK DAY MEDIA
(NASDAQ:PSYC)
08/12/2022 17:15
CanaQuest Achieves Statistically Significant Reduction of Seizures for Epilepsy Compared to Standard CBD
Lire la news
Voir tous les communiqués de Stock Day Media
STOCK DAY MEDIA
(NASDAQ:PSYC)
08/09/2022 15:00
Canaquest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via WWW.CANAQUESTSTORE.COM, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD
Lire la news
Voir tous les communiqués de Stock Day Media
1
2
3
4
5
6
7
8
9
10